OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← British Society For The Study Of Vulval Diseases

2025-04-30-accounts

Charity registration number 1081697 (England and Wales) Company registration number 03545455

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2025

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Dr A Almadori Dr T F M Vergeldt Dr AA Krishna Ms TJ Robinson Dr RC Simpson Dr WY Chan Dr LE Clarke Dr S Harish Dr VG Nicolson-Ford Dr SL Rees Dr S Whiteway Mrs AO Williams Charity number (England and Wales) 1081697 Company number 03545455 Principal address Colposcopy Department St Mary Hospital Oxford Road Manchester M13 9WL Registered office Charlotte House Stanier Way The Wyvern Business Park Derby DE21 6BF Independent examiner Philip Handley FCA c/o Dains Accountants Cubo, Standard Court Park Row Nottingham NG1 6GN

(Appointed 20 June 2024) (Appointed 6 June 2024)

(Appointed 5 June 2025) (Appointed 5 June 2025) (Appointed 1 September 2025) (Appointed 1 August 2025) (Appointed 5 June 2025) (Appointed 5 June 2025) (Appointed 5 June 2025)

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

CONTENTS

Page
Trustees' report 1 - 3
Independent examiner's report 4
Statement of financial activities 5
Balance sheet 6
Notes to the financial statements 7 - 12

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 30 APRIL 2025

The trustees present their annual report and financial statements for the year ended 30 April 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019).

Objectives and activities

We are a true multidisciplinary society largely made up from the specialties of gynaecology, dermatology, genitourinary medicine and pathology. Our membership consists of doctors and nurses and we work closely with allied health professionals aligned to vulval disease. This multidisciplinary approach to the speciality enables excellence in clinical outcomes and workforce training. We have a strong commitment to education and training working with our medical colleges striving to achieve high quality standards of care for patients. The objectives of the society are:-

Public benefit

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.

Achievements and performance

Significant activities and achievements against objectives

Achievements in the last financial year include:

Research

Co-funded two research awards with the Wellbeing of Women

Co-funded one research award with the British Skin Foundation

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

Financial review

Net expenditure for the year was £904 (2024 net expenditure was £1,839) leaving reserves of £56,796 (2024 £57,700) to be carried forward.

Reserves policy

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to two years expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.

Structure, governance and management

The charity is a company limited by guarantee, not having share capital and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up, such amounts as may be required not exceeding £10.

The BSSVD Council is the governing committee that is responsible for the financial and legal status of the BSSVD as a charity. It oversees what the society does and sets the strategic direction of the society. All council members are volunteers. The Council usually meets twice a year.

The trustees who served during the year and up to the date of signature of the financial statements were:

Dr U Winters (Resigned 5 June 2024)
Dr D Nunns (Resigned 17 May 2024)
Dr VN Sivalingam (Resigned 31 October 2025)
Dr L Kirby (Resigned 30 September 2025)
Dr A Almadori (Appointed 20 June 2024)
Dr T F M Vergeldt (Appointed 6 June 2024)
Professor R Murphy (Resigned 25 March 2025)
Dr AA Krishna
Dr M D C Fox (Resigned 5 June 2025)
Dr S Schoeman (Resigned 7 April 2025)
Dr J Smith (Resigned 15 February 2025)
Ms TJ Robinson
Dr RC Simpson
Dr K Robinson (Resigned 1 May 2025)
Dr WY Chan (Appointed 5 June 2025)
Dr LE Clarke (Appointed 5 June 2025)
Dr S Harish (Appointed 1 September 2025)
Dr VG Nicolson-Ford (Appointed 1 August 2025)
Dr SL Rees (Appointed 5 June 2025)
Dr S Whiteway (Appointed 5 June 2025)
Mrs AO Williams (Appointed 5 June 2025)

Recruitment and appointment of trustees

Appointment of trustees

The directors of the company are also charity trustees. The number of trustees shall be not less than three and not subject to any maximum. Under the requirements of the Articles of Association, one third of the trustees who are subject to retirement by rotation shall retire from office but are eligible for re-election annually. New trustees are appointed by ordinary resolution by the trustees. On appointment, trustees are (depending on the level of their experience) briefed on their responsibilities as trustees. As it is the present policy only to appoint trustees with relevant experience, formal induction and training has not been considered necessary.

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.

The trustees have considered those areas potentially creating the greatest risk to the charity, particularly those in relation to financial, compliance and regulatory issues and are satisfied that adequate steps have been taken to mitigate exposure to these risks.

The trustees' report was approved by the Board of Trustees.

..............................

Dr LE Clarke Trustee

Date: .............................................

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

INDEPENDENT EXAMINER'S REPORT

TO THE TRUSTEES OF THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

I report to the trustees on my examination of the financial statements of The British Society for the Study Of Vulval Diseases (the charity) for the year ended 30 April 2025.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law), you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006.

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Philip Handley FCA

Institute of Chartered Accountants in England and Wales c/o Dains Accountants Cubo, Standard Court Park Row Nottingham NG1 6GN Date: ............................

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 30 APRIL 2025

Unrestricted Unrestricted
funds funds
2025 2024
Notes £ £
Income and endowments from:
Donations and legacies 3 10,000 -
Charitable activities 4 46,717 27,333
Other income 5 5,501 -
Total income 62,218 27,333
Expenditure on:
Charitable activities 6 63,122 29,172
Total charitable expenditure 63,122 29,172
Net expenditure and movement in funds (904) (1,839)
Reconciliation of funds:
Fund balances at 1 May 2024 57,700 59,539
Fund balances at 30 April 2025 56,796 57,700

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

BALANCE SHEET

AS AT 30 APRIL 2025

Notes
Current assets
Debtors
12
Cash at bank and in hand
Creditors: amounts falling due within
one year
13
Net current assets
The funds of the charity
Unrestricted funds
15		 2025
£
1,350
57,602
58,952
(2,156)		 2024
£
£
-
69,636
69,636
(11,936)
56,796
56,796
56,796		 £
57,700
57,700
57,700

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 30 April 2025.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees on .........................

.............................. Dr LE Clarke Trustee

Company registration number 03545455 (England and Wales)

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2025

1 Accounting policies

Charity information

The British Society for the Study Of Vulval Diseases is a public benefit entity and a private company limited by guarantee, incorporated in England and Wales and a registered charity in England and Wales. The registered office is Charlotte House Stanier Way, The Wyvern Business Park, Derby, England, DE21 6BF. The liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up, such amounts as may be required not exceeding £10. The company was established under a Memorandum of Association which established the objects and powers of the charitable company and is governed under its Articles of Association.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Income from subscriptions and event income are recognised on receipt.

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.

Costs are apportioned between support and governance costs on the basis of actual time allocations.

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

1 Accounting policies

(Continued)

1.6 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Donations and legacies

Unrestricted Total
funds
2025 2024
£ £
Grants receivable 10,000 -

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 30 APRIL 2025

4 Income from charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Charitable activities
Membership fees 18,246 16,415
Event income 28,471 10,918
46,717 27,333

5 Other income

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Other income 5,501 -
Other income relates to the receipt of unused grant funds.

6 Expenditure on charitable activities

Unrestricted Unrestricted
funds funds
2025 2024
£ £
Direct costs
Administration costs 7,226 -
Sundry expenses 280 359
Bank charges 676 501
Awards and prizes 19,766 1,030
Donations 7,698 -
Research services for study 24,999 24,737
60,645 26,627
Share of support and governance costs (see note 7)
Governance 2,477 2,545
63,122 29,172
Analysis by fund
Unrestricted funds 63,122 29,172

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

7 Support costs allocated to activities

Governance costs
Analysed between:
Unrestricted funds
Governance costs comprise:
Independent examination fees
Accountancy
8
Net movement in funds
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements		 2025
£
2,477
2,477
2025
£
900
1,577
2,477
2025
£
900		 2024
£
2,545
2,545
2024
£
900
1,645
2,545
2024
£
900

9 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits or expenses from the charity during the year.

10 Employees

The average monthly number of employees during the year was:

2025 2024
Number Number
Total - -

There were no employees whose annual remuneration was more than £60,000.

11 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

12
Debtors
2025
Amounts falling due within one year:
£
Prepayments and accrued income
1,350
13
Creditors: amounts falling due within one year
2025
Notes
£
Deferred income
14
-
Accruals
2,156
2,156
14
Deferred income
2025
£
Other deferred income
-
Deferred income is included in the financial statements as follows:
2025
£
Deferred income is included within:
Current liabilities
-
Movements in the year:
Deferred income at 1 May 2024
10,000
Released from previous periods
(10,000)
Resources deferred in the year
-
Deferred income at 30 April 2025
-		 2024
£
-
2024
£
10,000
1,936
11,936
2024
£
10,000
2024
£
10,000
-
-
10,000
10,000

15 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1 May 2024 Incoming Resources At 30 April
resources expended 2025
£ £ £ £
General funds 57,700 62,218 (63,122) 56,796

THE BRITISH SOCIETY FOR THE STUDY OF VULVAL DISEASES

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 APRIL 2025

15 Unrestricted funds (Continued)
Previous year: At 1 May 2023 Incoming Resources At 30 April
resources expended 2024
£ £ £ £
General funds 59,539 27,333 (29,172) 57,700
16 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).